Skip to content

300: Where Bioprocess Models Deliver and Where They Overpromise: Choosing Between Hybrid, Mechanistic, and Machine Learning with Moritz von Stosch - Part 2

October 29, 2026 · 22 min

Show notes

Is your process model gathering dust while real-world decisions march on without it? Many technically strong digital tools—no matter how powerful—end up sidelined in bioprocess development. Why is that, and what does it actually take for digital modeling to earn its place at the lab bench?

In this episode, David Brühlmann sits down with Moritz von Stosch of HINA Bioventures, a scientist-turned-investor who’s navigated both the technology provider and pharma end-user sides. Moritz von Stosch brings firsthand insights from building digital solutions, deploying them in pharma, and evaluating what actually sticks when the clock is ticking and the stakes are high.

Topics discussed:

  • The importance of starting with your purpose when selecting a modeling strategy (03:00)
  • Experimental design: when to use factorial versus random space-filling designs, and the inherent biases each can introduce (04:22)
  • The future of agentic workflows, AI, and autonomous labs in bioprocessing, including the importance and challenges of sensor technologies (06:02)
  • Practical hurdles to implementing fully autonomous laboratories, and the non-obvious value humans still bring (09:09)
  • Adapting mindsets for the evolving role of the bioprocess engineer in a more automated, agent-driven workflow (11:48)
  • Advice for biotech professionals on how to assess the real value in new technologies versus hype, and the role of proprietary algorithms and company stability (13:33)
  • How cultural factors, not just technology, shape the adoption of modeling and digital tools in biotech (16:02)
  • Strategies to help the bioprocess community adopt more innovation while ensuring compliance in regulated environments (17:14)
  • Three key takeaways for staying relevant—including generating data for tomorrow’s questions and balancing curiosity, experimentation, and oversight (19:14)

Smart insight: Three takeaways from Moritz von Stosch:

  1. Generate data for tomorrow’s questions, not just today’s.
  2. Be curious—try, adapt, don’t over-plan.
  3. Stay relevant: Use digital tools but keep your human edge (creativity, critical thinking).

To keep exploring how modeling and prior knowledge can speed up process development, check out these related conversations:

  • Episodes 05 - 06: Hybrid Modeling: The Key to Smarter Bioprocessing with Michael Sokolov
  • Episodes 173 - 174: Mastering Hybrid Model Digital Twins: From Lab Scale to Commercial Bioprocessing with Krist Gernaey
  • Episodes 277 - 278: Your Bioprocess Data Already Holds 35% More Yield: From End-to-End Models to Digital Twins with Ignasi Bofarull-Manzano
  • Episodes 215 - 216: From Data Silos to Autonomous Biomanufacturing: Digital Twins and AI-Driven Scale-Up with Ilya Burkov

Connect with Moritz von Stosch:
Website: www.hinabioventures.com
LinkedIn: www.linkedin.com/in/movosto

Support the show

All episodes of Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.